Quel est le prix pour CardioComm Solutions, Inc. (EKGGF)

Le prix pour CardioComm Solutions, Inc. (EKGGF) est $0.0109

Quelle est la capitalisation boursière pour CardioComm Solutions, Inc. (EKGGF)

La capitalisation boursière pour CardioComm Solutions, Inc. (EKGGF) est $2.15M

CardioComm Solutions, Inc. (EKGGF) Prix et Capitalisation Boursière

CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada, specializes in developing advanced technological solutions for cardiac monitoring. The company delivers both sophisticated software and hardware products, as well as core laboratory reading services, specifically designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems. These comprehensive offerings cater to both the medical sector and individual consumers across the globe. At the heart of CardioComm's operations is proprietary technology that underpins the entire ECG workflow: from initial recording and seamless transmission to detailed viewing, in-depth analysis, comprehensive reporting, and secure long-term storage. This end-to-end capability is crucial for the effective screening, accurate diagnosis, and ongoing management of cardiac patients. Their unique device connectivity and ECG management platforms are integrated into diverse solutions, spanning general medical applications, consumer-grade health products, clinical research initiatives, and modern telemedicine services. The company's extensive software suite includes the Global ECG Management System (GEMS) for cardiac event monitoring, GlobalCardio 12 Lead—a web-enabled and EMR-compatible ECG device—and GEMS Lite for Windows, an electronic system for receiving ECG data. Complementary software modules further enhance their offerings, such as GEMS WIN Air for live wireless ECG monitoring, AutoAttendant to empower healthcare providers by automating routine tasks, and the GEMS HL7 Interface, which ensures compliant data exchange with other EMR systems. Additionally, GlobalCardio EMR integration facilitates the bi-directional transfer of crucial information, including patient data, reports, and related links. Beyond software, CardioComm provides a range of hardware products. These include the portable HeartCheck PEN and HeartCheck handheld ECG monitors, various Sirona telephonic and wireless event recorders, and the HeartCheck CardiBeat device. Furthermore, the company offers Application Service Provider (ASP) solutions, notably C4 ECG management services and HeartCheck SMART Monitoring. Their broader product portfolio also features GlobalCardio 3 Lead, the ECG Viewer SDK, QRS Diagnostic, and QRS 12 Lead Universal.

Prix pour EKGGF	L’actif B	La capitalisation boursière de B	Résultats
$27,591.88 $2.15M	NVDA	$5.452T	+253,136,451.41%
$22,723.98 $2.15M	AAPL	$4.490T	+208,476,751.78%
$21,065.93 $2.15M	GOOG	$4.162T	+193,265,292.67%
$18,605.96 $2.15M	MSFT	$3.676T	+170,696,749.66%
$14,338.02 $2.15M	AMZN	$2.833T	+131,541,359.80%

Prix pour EKGGF

L’actif B

La capitalisation boursière de B

Résultats

$27,591.88 $2.15M